2,851
edits
Line 41: | Line 41: | ||
|Co-administration with Piperine||Bioavailability Enhanced Quercetin, Piperine-Quercetin Combination||Approximately 20%||Inhibits metabolism of quercetin, improving its bioavailability. | |Co-administration with Piperine||Bioavailability Enhanced Quercetin, Piperine-Quercetin Combination||Approximately 20%||Inhibits metabolism of quercetin, improving its bioavailability. | ||
|} | |} | ||
===Metabolism and Bioavailability=== | ===Metabolism and Bioavailability=== |